The role of biobanks in advancing the national biotechnology strategy in Saudi Arabia
The Saudi Biobank is considered one of the most advanced health initiatives in the Eastern Mediterranean Region. To enhance its impact, there is a need to strengthen its capacity through increased and sustained investments, improved data interoperability and data integration, standardised governance systems, increased national and international partnerships and collaborations, and other policy reforms.
Authors
- Lubna Alnasser (ORCID: https://orcid.org/0009-0004-1442-5293)
- A Ghamari Zare (ORCID: https://orcid.org/0000-0001-5922-3143)
- Zisis Kozlakidis (ORCID: https://orcid.org/0000-0002-3836-7209)
- Tariq Alqahtani (ORCID: https://orcid.org/0009-0007-1094-6835)
- Hisham A. Badreldin (ORCID: https://orcid.org/0000-0001-7182-4347)
- Abdulrhman Aljouie (ORCID: https://orcid.org/0000-0002-5592-2462)
- Dalal Aldeghaither
- Nadin Almosnid
- Alaa Alshareeda
- Sausan Alfaris
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
- Centre international de recherche sur le cancer (FR)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Eastern Mediterranean Health Journal
- Published
- 2025-12-08
- DOI
- https://doi.org/10.26719/2025.31.11.649
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Ministry of National Guard Health Affairs
- King Abdullah International Medical Research Center
- King Saud bin Abdulaziz University for Health Science